View All Patents
EP4051265
Unitary patentFUNCTIONALIZED PEPTIDES AS ANTIVIRAL AGENTS
Filed
Jul 19, 2021
Technology
Chemistry · Pharmaceuticals +1
UPC cases
1
EPO proceedings
1
Ownership history
As recorded at the EPO. Transfers made after the opposition period are recorded in national registers and may be missing here.
- Enanta Pharmaceuticals, Inc.since Aug 5, 2022
Abstract
The present invention discloses compounds of Formula (I), and pharmaceutically acceptable salts, thereof: which inhibit coronavirus replication activity. The invention further relates to pharmaceutical compositions comprising a compound of Formula (I) or a pharmaceutically acceptable salt thereof, and methods of treating or preventing a coronavirus infection in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a compound of Formula (I) or a pharmaceutically acceptable salt thereof.
From the international application WO2022020242
Litigation history
| Date | Case | Division | Type | Outcome | Parties |
|---|---|---|---|---|---|
| Aug 20, 2025 | UPC CFI 768/2025 | Munich LD | Infringement | Locked | Enanta Pharmaceuticals, Inc. +18 |
Additional proceedings on this patent
Start 14-day free trialOutcomes, the additional proceedings and the register history.Already a user? Sign in